Evofem Biosciences's market cap is currently ―. The company's EPS TTM is $-7.911; its P/E ratio is >-0.01; Evofem Biosciences is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 5.11M	$ 2.46M	$ 181.00K	$ 6.37M	$ 6.03M
Gross Profit	$ 3.22M	$ 165.00K	$ -203.00K	$ 4.69M	$ 4.75M
EBIT	$ 67.10M	$ -7.48M	$ -9.98M	$ 89.47M	$ -24.42M
EBITDA	$ 67.14M	$ -7.31M	$ -9.73M	-	$ -24.17M
Net Income Common Stockholders	$ 66.00M	$ -8.56M	$ -11.48M	$ 89.51M	$ -124.07M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 636.00K	$ 3.98M	$ 9.04M	$ 19.89M
Total Assets	$ 13.32M	$ 14.07M	$ 25.16M	$ 42.28M	$ 53.47M
Total Debt	$ 41.23M	$ 43.20M	$ 5.44M	$ 6.22M	$ 125.74M
Net Debt	$ 41.23M	$ 42.56M	$ 1.47M	$ -2.82M	$ 105.85M
Total Liabilities	$ 67.88M	$ 69.74M	$ 96.96M	$ -35.24M	$ 269.47M
Stockholders Equity	$ -56.36M	$ -55.66M	$ -71.80M	$ -78.04M	$ -216.00M
Cash Flow	-
Free Cash Flow	$ -2.36M	$ -1.50M	$ -6.57M	$ -16.37M	$ -26.83M
Operating Cash Flow	$ -2.36M	$ -1.49M	$ -6.53M	$ -16.30M	$ -26.66M
Investing Cash Flow	-	$ -1.00K	$ -35.00K	$ -70.00K	$ -170.00K
Financing Cash Flow	$ 2.14M	$ 597.00K	$ 1.50M	$ 3.95M	$ 41.36M

Currency in USD

Evofem Biosciences Earnings and Revenue History

Income Statement >

Evofem Biosciences Debt to Assets

Balance Sheet >

Evofem Biosciences Cash Flow

Cash Flow >

Evofem Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing